Literature DB >> 25958189

Simultaneous PET/MR head-neck cancer imaging: Preliminary clinical experience and multiparametric evaluation.

M Covello1, C Cavaliere2, M Aiello2, M S Cianelli2, M Mesolella3, B Iorio3, A Rossi2, E Nicolai2.   

Abstract

PURPOSE: To evaluate the role of simultaneous hybrid PET/MR imaging and to correlate metabolic PET data with morpho-functional parameters derived by MRI in patients with head-neck cancer.
METHODS: Forty-four patients, with histologically confirmed head and neck malignancy (22 primary tumors and 22 follow-up) were studied. Patients initially received a clinical exam and endoscopy with direct biopsy. Next patients underwent whole body PET/CT followed by PET/MR of the head/neck region. PET and MRI studies were separately evaluated by two blinded groups (both included one radiologist and one nuclear physician) in order to define the presence or absence of lesions/recurrences. Regions of interest (ROIs) analysis was conducted on the primary lesion at the level of maximum size on metabolic (SUV and MTV), diffusion (ADC) and perfusion (K(trans), Ve, kep and iAUC) parameters.
RESULTS: PET/MR examinations were successfully performed on all 44 patients. Agreement between the two blinded groups was found in anatomic allocation of lesions by PET/MR (Primary tumors: Cohen's kappa 0.93; FOLLOW-UP: Cohen's kappa 0.89). There was a significant correlation between CT-SUV measures and MR (e.g., CT-SUV VOI vs. MR-SUV VOI: ρ=0.97, p<0.001 for the entire sample). There was also significant positive correlations between the ROI area, SUV measures, and the metabolic parameters (SUV and MTV) obtained during both PET/CT and PET/MR. A significant negative correlation was observed between ADC and K(trans) values in the primary tumors. In addition, a significant negative correlation existed between MR SUV and ADC in recurrent tumors.
CONCLUSION: Our study demonstrates the feasibility of PET/MR imaging for primary tumors and recurrent tumors evaluations of head/neck malignant lesions. When assessing HNC, PET/MR allows simultaneous collection of multiparametric metabolic and functional data. This technique therefore allows for a more complete characterization of malignant lesions.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  DCE; DWI; Head and neck cancer; Hybrid imaging; PET/MR; SUV

Mesh:

Substances:

Year:  2015        PMID: 25958189     DOI: 10.1016/j.ejrad.2015.04.010

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  24 in total

Review 1.  Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist.

Authors:  Jon Cacicedo; Arturo Navarro; Olga Del Hoyo; Alfonso Gomez-Iturriaga; Filippo Alongi; Jose A Medina; Olgun Elicin; Andrea Skanjeti; Francesco Giammarile; Pedro Bilbao; Francisco Casquero; Berardino de Bari; Alan Dal Pra
Journal:  Br J Radiol       Date:  2016-08-02       Impact factor: 3.039

Review 2.  [Molecular imaging of head and neck cancers : Perspectives of PET/MRI].

Authors:  P Stumpp; S Purz; O Sabri; T Kahn
Journal:  Radiologe       Date:  2016-07       Impact factor: 0.635

Review 3.  Recent advances in MRI of the head and neck, skull base and cranial nerves: new and evolving sequences, analyses and clinical applications.

Authors:  Philip Touska; Steve E J Connor
Journal:  Br J Radiol       Date:  2019-09-24       Impact factor: 3.039

4.  Comparison of 18F-FDG PET/MRI, MRI, and 18F-FDG PET/CT for the detection of synchronous cancers and distant metastases in patients with oropharyngeal and hypopharyngeal squamous cell carcinoma.

Authors:  Chih-Hua Yeh; Sheng-Chieh Chan; Chien-Yu Lin; Tzu-Chen Yen; Joseph Tung-Chieh Chang; Sheung-Fat Ko; Kang-Hsing Fan; Hung-Ming Wang; Chun-Ta Liao; Shu-Hang Ng
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-10-12       Impact factor: 9.236

5.  Simultaneous PET/MRI in assessing the response to chemo/radiotherapy in head and neck carcinoma: initial experience.

Authors:  Valeria Romeo; Brigida Iorio; Massimo Mesolella; Lorenzo Ugga; Francesco Verde; Emanuele Nicolai; Mario Covello
Journal:  Med Oncol       Date:  2018-06-19       Impact factor: 3.064

6.  Clinical utility of simultaneous whole-body 18F-FDG PET/MRI as a single-step imaging modality in the staging of primary nasopharyngeal carcinoma.

Authors:  Sheng-Chieh Chan; Chih-Hua Yeh; Tzu-Chen Yen; Shu-Hang Ng; Joseph Tung-Chieh Chang; Chien-Yu Lin; Tsang Yen-Ming; Kang-Hsing Fan; Bing-Shen Huang; Cheng-Lung Hsu; Kai-Ping Chang; Hung-Ming Wang; Chun-Ta Liao
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-03-03       Impact factor: 9.236

Review 7.  Longitudinal PET imaging of tumor hypoxia during the course of radiotherapy.

Authors:  Sonja Stieb; Afroditi Eleftheriou; Geoffrey Warnock; Matthias Guckenberger; Oliver Riesterer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-08-20       Impact factor: 9.236

Review 8.  FDG Whole-Body PET/MRI in Oncology: a Systematic Review.

Authors:  Hyun Woo Kwon; Ann-Katharina Becker; Jin Mo Goo; Gi Jeong Cheon
Journal:  Nucl Med Mol Imaging       Date:  2016-04-07

Review 9.  18F-FDG PET/CT and PET/MRI Perform Equally Well in Cancer: Evidence from Studies on More Than 2,300 Patients.

Authors:  Claudio Spick; Ken Herrmann; Johannes Czernin
Journal:  J Nucl Med       Date:  2016-01-07       Impact factor: 10.057

Review 10.  Application of positron emission tomography/computed tomography in radiation treatment planning for head and neck cancers.

Authors:  Musaddiq J Awan; Farzan Siddiqui; David Schwartz; Jiankui Yuan; Mitchell Machtay; Min Yao
Journal:  World J Radiol       Date:  2015-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.